Incorporation of a nanosplitter interface into an LC-MS-RD system to facilitate drug metabolism studies.
In the work reported here, a novel interface, the nanosplitter, is incorporated into the drug metabolism laboratory in order to enhance the analytical capabilities of detecting and identifying drug-related metabolites to support drug metabolism studies during the drug development process. When an existing LC-MS-radiometric detector (RD) system is coupled with this nanosplitter, the system becomes capable of performing dynamic microspray under a typical analytical LC method. With the superior MS sensitivity offered by this system, most of the analytical LC methods developed for metabolite profiling can then be easily adopted for metabolite identification work. The improvement of these analytical capabilities can streamline the entire process of the drug metabolism study. In the experiments presented here, the nanosplitter interface coupled with analytical HPLC systems (e.g. 4.6 x 250 mm column @ 1 ml/min) demonstrated significant increases in MS signal (2x to 40x peak area) when compared to the standard LC-MS interface for both in vitro and in vivo metabolism studies. Furthermore, this signal gain facilitated the MS detection of additional metabolites (observed in the radiometric trace) that were below the MS level of detection when using the standard interface.
Andrews
Christine L
CL
Department of Chemistry and Chemical Biology, Barnett Institute, Northeastern University, Boston, MA 02115, USA.
Li
Feng
F
Yang
Eric
E
Yu
Chung-Ping
CP
Vouros
Paul
P
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation*; D038341:Glycogen Synthase Kinases / Q000737:chemistry / Q000378:metabolism; D000882:Haplorhini; D022781:Hepatocytes / Q000737:chemistry; D013058:Mass Spectrometry / Q000295:instrumentation*; D036103:Nanotechnology; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism* / Q000652:urine; D051381:Rats; D012015:Reference Standards
D004364:Pharmaceutical Preparations; D038341:Glycogen Synthase Kinases